Biohaven
BHVN
176 hedge funds and large institutions have $910M invested in Biohaven in 2023 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 53 increasing their positions, 45 reducing their positions, and 34 closing their positions.
18% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 45
5.93% more ownership
Funds ownership: 91.63% → 97.56% (+5.9%)
5% more capital invested
Capital invested by funds: $868M → $910M (+$41.8M)
0% more funds holding
Funds holding: 176 → 176 (0)
0% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 34
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
36% less call options, than puts
Call options by funds: $5.95M | Put options by funds: $9.35M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$23.7M |
| 2 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$19.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.3M |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
+$14.3M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$11.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$8.81M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$7.66M |
| 3 |
AG
Artal Group
Luxembourg
|
-$6.94M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$6.93M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$6.61M |
BHVN Hedge Fund Activity: Q1 2023 in Review
176 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Biohaven (BHVN) for Q1 2023, worth a combined $910M — up 4.8% from $868M a quarter earlier.
Fund positioning in BHVN was balanced in Q1 2023: 34 funds opened new positions, 34 closed out, 53 added to existing stakes and 45 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $23.7M. The largest seller was Marshall Wace, cutting an estimated $8.81M.
- 176 institutional investors held Biohaven (BHVN) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $910M of Biohaven stock for Q1 2023, up 4.8% quarter-over-quarter.
- 34 funds opened new Biohaven positions in Q1 2023 and 34 closed out, a net change of 0 holders.
- The largest Biohaven buyer in Q1 2023 was Point72 Asset Management, an estimated $23.7M added.
- The largest Biohaven seller in Q1 2023 was Marshall Wace, an estimated $8.81M sold.
Based on aggregated 13F filings for Q1 2023.